21025 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Transferases (2)
Somatostatin 2 receptor (sst2), deoxycytidine kinase (dck) and uridine monophosphate kinase (umk) pancreatic gene therapy
#1202VISFATIN THERAPEUTIC AGENTS FOR THE TREATMENT OF ACNE AND OTHER CONDITIONS
#1203COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#1204PREPARATION FOR IMPROVING THE PROTECTION OF HUMAN CELLS, ESPECIALLY CELLS OF THE HUMAN SKIN, FROM THE HARMFUL INFLUENCES OF OXIDATIVE NOXAE AND UV RADIATION
#1205Treating post-seizure patients
#1206Pharmaceutical and/or cosmetic composition containing an active antioxydant principle and cell energy activator
#1207MEMORY ENHANCING PROTEIN
#1208Means and methods for the recruitment and identification of stem cells
#1209USE OF SIRT7 FOR TREATING AGE-RELATED DISEASES
#1210Methods and pharmaceutical compositions for healing wounds
#1211HAT ACETYLATION PROMOTERS AND USES OF COMPOSITIONS THEREOF IN PROMOTING IMMUNOGENICITY
#1212Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
#1213ANTI-TUMORAL COMPOSITIONS METHODS
#1214METHODS OF USING BENFOTIAMINE AND PYRIDOXAMINE COMPOSITIONS
#1215GOOD TASTING FOOD PRODUCT CONTAINING AN AGENT FOR REDUCING CARBOHYDRATE UPTAKE; AND COMPOSITIONS CONTAINING SUCH AN AGENT
#1216COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
#1217Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
#1218METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS
#1219Solid fibrinogen preparation
#1220Antibodies Against Cancer
#1221Recombinant VSV For The Treatment of Tumor Cells
#1222Method for Treating Pain with a Calmodulin Inhibitor
#1223Methods of treating Parkinson's disease using viral vectors
#1224Wound healing
#1225Vault and vault-like carrier molecules
#1226Cosmetic Methods And Compositions For Repairing Human Skin
#1227Inhibition of mitogen-activated protein kinases in cardiovascular disease
#1228Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases
#1229Formulations for nonsurgical exogenous crosslink therapy
#1230FORMULATIONS FOR NONSURGICAL EXOGENOUS CROSSLINK THERAPY
#1231SYNERGISTIC EFFECT BETWEEN A CYANOGENIC SYSTEM AND ANOTHER OXIDATIVE INDUCING SYSTEM FOR TREATING TUMORS
#1232Pathotropic targeted gene delivery system for cancer and other disorders
#1233Methods and Compositions for Treating Disease
#1234Protein kinase C therapy for the treatment of acute lung injury
#1235Role of the Mk2 Pathway in Wound Repair
#1236Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#1237Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis
#1238METHOD OF TREATING ACUTE ST-ELEVATION MYOCARDIAL INFARCTION WITH A DELTA PKC ANTAGONIST
#1239Methods to predict and prevent resistance to taxoid compounds
#1240Transfection of Collagen-Producing Cells
#1241CLOSTRIDIUM BOTULINUM C3 EXOTRANSFERASE COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING
#1242Regenerating and enhancing development of muscle tissue
#1243REGULATION OF MUSCLE REPAIR
#1244Methods of increasing cerebral blood flow
#1245Use of Blood Coagulation Factor XIII for Treating Hemophilia A
#1246Genetic variations associated with psychiatric disorders
#1247PROCESS FOR CONCENTRATION OF A POLYPEPTIDE
#1248Hip kinase for fertility control
#1249Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#1250Chimeric adenoviruses for use in cancer treatment
#1251NOVEL PHARMACEUTICAL COMPOSITIONS FOR MODULATING ANGIOGENESIS
#1252METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING
#1253VEGF-activated ligands
#1254Tumor therapy with replication competent sindbis viral vectors
#1255Generation of Replication Competent Viruses for Therapeutic Use
#1256TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM
#1257Modulation of the integrin-linked kinase signaling pathway provides beneficial human cardiac hypertrophy and post myocardial infarction remodeling
#1258Peptide inhibitors of protein kinase C
#1259Methods and pharmaceutical compositions for healing wounds
#1260Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition
#1261INHIBITION OF PROTEIN KINASE C ALPHA FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
#1262Chondroitin sulfate synthesis promoter
#1263Polypeptide targeting to mitochondria
#1264Compounds for improving nutritional status, cognition and survival
#1265Wound healing
#1266Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
#1267NOVEL MODIFICATION OF IMMUNOMODULATORY PROTEIN
#1268Characterization of a MEKK binding site and uses thereof
#1269USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER
#1270Methods and compositions for polypeptide engineering
#1271Peptide inhibitors of protein kinase C gamma for pain management
#1272Telomerase delivery by biodegradable Nanoparticle
#1273METABOLIC REGULATORS AND USES THEREOF
#1274COMPOSITIONS AND METHODS FOR TREATING TUMOUR SPREADING
#1275Inhibition of tumor metastases using protein kinase C (PKC) inhibitors
#1276Systems and methods for viral therapy
#1277Detection of mutations in a gene associated with resistance to viral infection, OAS1
#1278Antibodies Against Cancer
#1279FGFR AGONISTS
#1280Lumican proteoglycan in the diagnosis and treatment of atherosclerosis
#1281Molecular signature of cancer
#1282Methods for stabilizing corneal tissue
#1283Composition and method for killing of tumours
#1284Methods of promoting growth of muscle tissue using ALK7
#1285Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility
#1286Peptides derived from the C2 domain of epsilon PKC
#1287Inositol pyrophosphates determine exocytotic capacity
#1288THYMIDYLATE KINASE MUTANTS AND USES THEREOF
#1289Compositions for promoting wound healing and treating psoriasis
#1290Methods of use of epsilon inhibitor compounds for the attenuation of pain
#1291Methods for maintaining blood-brain barrier integrity in hypertensive subjects using a delta-PKC inhibitor
#1292METHODS OF USE OF GAMMA INHIBITOR COMPOUNDS FOR THE ATTENUATION OF PAIN
#1293Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
#1294Methods for inhibiting angiogenesis and tumor growth by inhibition of beta or delta protein kinase C
#1295KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF A CALRETICULIN PROTEIN TO A CELLULAR MEMBRANE
#1296COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN
#1297sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis
#1298CANCER TREATMENT BY METABOLIC MODULATIONS
#1299Use of Blood Coagulation Factor XIII for Treating Hemophilia A
#1300PHARMACEUTICAL COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC AND SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER USING CRT OR ERP57 TRANSLOCATION
#1301VISFATIN AND USES THEREOF
#1302METHOD, APPARATUS, AND COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER
#1303Compositions and methods for improving heart function
#1304METHODS AND COMPOSITIONS FOR NERVE REGENERATION
#1305METHODS FOR DETECTING AGENTS INVOLVED IN NEURONAL APOPTOSIS AND COMPOSITIONS THEREOF
#1306METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS
#1307ARYLPIPERIDINYL AND ARYLPYRROLIDINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
#1308Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal
#1309Method for Treating Neurological Disorders
#1310Methods for identifying modulators of protein kinase C-epsilon (PKC) and method of treatment of aberrant glucose metabolism associated therewith
#1311Single-dose administration of Factor VIIa
#1312Neukinase, a downstream protein of neuregulin
#1313Production of Bioavailable Folic Acid
#1314Methods and compositions for treating and preventing neurologic disorders
#1315MUC1-IκB kinase complexes and their activities
#1316Method and composition for increasing Erythropoietin
#1317Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#1318RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth
#1319Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#1320Compositions and methods for cell dedifferentiation and tissue regeneration
#1321Method to Enhance the Bone Formation Activity of Bmp by Runx2 Acetylation
#1322Hemostatic materials and dressing
#1323Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
#1324Agent for treating allergic or hypersensitivity condition
#1325Novel Indications for Transforming Growth Factor-Beta Regulators
#1326Treating immunodeficiencies by intrathymic injection of nucleotide sequences
#1327Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism
#1328Method of treatment of myocardial infarction
#1329Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
#1330Aldehyde tags, uses thereof in site-specific protein modification
#1331Natural dietary supplement and method for enhancing human libido
#1332Degradation-resistant fibrinogen sealants
#1333THERAPEUTICS TO FACILITATE CELL TRANSPLANTATION FOR LIVER DISEASE
#1334Purification of Factor Xlll Polypeptides From Biological Materials
#1335Materials and Methods for Prevention and Treatment of RNA Viral Diseases
#1336Peptide inhibitors of protein kinase C
#1337Materials and methods for treating or preventing oxalate-related disease
#1338Memory influencing protein
#1339Methods for Chk2 inhibitor patient selection
#1340Activation and inhibition of the immune system
#1341Oligoadenylate Synthetase (OAS)
#1342Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins
#1343Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo
#1344Method of restoring the incretin effect
#1345Methods for treating atherosclerosis
#1346Methods for treating cancers and restenosis with P21
#1347Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma
#1348Method of treating cell-migration conditions or diseases
#1349Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#1350Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor
#1351Compositions and methods for the diagnosis and treatment of cancer
#1352Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity
#1353Vectors for Recombinant Protein Expression in E. Coli
#1354TREATMENT OF PROSTATE CANCER BY INHIBITING LYN-TYROSINE KINASE
#1355Enzymatic debridement therapy for abnormal cell proliferation
#1356Methods of modulating angiogenesis
#1357Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading
#1358CANCER TREATMENT COMPOSITIONS AND METHOD USING NATURAL PLANT ESSENTIAL OILS
#1359Fibrin adhesive granulate and method for its preparation
#1360Method for treatment of neurodegenerative diseases and the effects of aging
#1361GRP78 targeting peptides and methods employing same
#1362Method of preventing progression of hypertension-induced heart failure with PKC peptides
#1363Method for treating pain with a calmodulin inhibitor
#1364Macrocylic oximyl hepatitis C protease inhibitors
#1365PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII
#1366MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
#1367Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure
#1368Compounds for Enhanced Cancer Therapy
#1369Regulation of glucose and insulin levels by GnT-4 glycosyltransferase activity
#1370Gene therapy using replication competent targeted adenoviral vectors
#1371RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE
#1372Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
#1373Drug delivery means
#1374Therapeutic Applications of Aminolevulinate Synthase
#1375CHONDROITIN SULFATE SYNTHESIS PROMOTER
#1376Direct application of non-toxic crosslinking reagents to restabilize surgically destabilized intervertebral joints
#1377Method of treating a knee meniscus with a cross-linking reagent to increase resistance to tearing or rupturing
#1378Compositions and methods for oxalate reduction
#1379Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling
#1380PATHOTROPIC TARGETED GENE DELIVERY SYSTEM FOR CANCER AND OTHER DISORDERS
#1381Use of factor XIII for stimulating the perfusion of ischemic tissue
#1382Haemostatic sprays and compositions
#1383Detection of mutations in a gene associated with resistance to viral infection, OAS1
#1384Methods and compounds for modulating triglyceride and vldl secretion
#1385Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain
#1386(+)-TRANS-4-(1-AMINOETHYL)-1-(4-PYRIDYCARBAMOYL)-CYCLOHEXANE AND METHOD FOR PROMOTING NEURAL GROWTH IN THE CENTRAL NERVOUS SYSTEM AND IN A PATIENT AT A SITE OF NEURONAL LESION
#1387Adenoviral vectors having a protein IX deletion
#1388Method for treating inflammatory bowel disease
#1389Compositions and methods of treatment
#1390Method of modulating cellular transmigration and agents for use therein
#1391Stabilised compositions
#1392Method for modulating P53 activity via methylation
#1393Methods and compositions for the prevention and regression of neovascularization
#1394Agent for repairing corneal perception
#1395Targeting the histone code as a bacterial strategy for selectively modulating gene expression
#1396Method for reducing risk of and extent of injury due to stroke in hypertensive subjects
#1397Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same
#1398Method of reducing immunological tolerance to malignancy
#1399Methods and compositions for polypeptide engineering
#1400Recombinant adenoviral vector and method of use
#1401Use of blood coagulation factor XIII for treating hemophilia A
#1402Method for treating Hemophilia B
#1403Adenoviral vectors having a protein IX deletion
#1404Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis
#1405PROPHYLACTIC AND THERAPEUTIC TREATMENT OF THE DUCTAL EPITHELIUM OF A MAMMARY GLAND FOR CANCER
#1406Method of treatment of myocardial infarction
#1407Methods and pharmaceutical compositions for healing wounds
#1408Methods of preventing or treating cell migration mediated conditions or diseases
#1409Protein N-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other N-gylosylation-increasing methods, and engineered hosts expressing products with increased N-glycosylation
#1410Control of apoptosis
#1411Modulation of the synthesis of insulin
#1412Method of treating a disorder by suicide gene therapy
#1413Chimeric IL-10
#1414Methods For inhibiting angiogenesis, cell migration, cell adhesion, and cell survival
#1415Protein Arginine N-Methyltransferase 2 (PRMT-2)
#1416Neuronal regeneration and compound administration methods
#1417Methods for treating cancers and restenosis with p21
#1418Enhancing cell migration by increasing telomerase activity
#1419Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
#1420PINK-1 promoter
#1421Constitutively active phosphatidylinositol 3-kinase and uses thereof
#1422Methods and compositions for polypeptide engineering
#1423Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors
#1424Gene therapy for colorectal cancer
#1425Means and methods for the recruitment and identification of stem cells
#1426Method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase
#1427Pharmaceutical composition comprising a factor VIIa and a factor XIII
#1428Methods and systems for nerve regeneration
#1429Composition and method for killing of tumours
#1430Minibrain homologous proteins involved in the regulation of energy homeostasis
#1431Methods and compositions for polypeptide engineering
#1432Regulation of vascular endothelium using BMX tyrosine kinase
#1433Compositions and methods for inhibiting cell senescence and hyperproliferative disorders
#1434Methods of increasing cerebral blood flow
#1435Vault and vault-like carrier molecules
#1436Selective inhibition of rock1 in cardiac therapy
#1437Method of treating cancer
#1438Recombinant adenoviral vectors and methods of use
#1439Compositions and methods for treating tumor spreading
#1440Use of c-Jun or c-Jun activating agents such as UV or c-Jun N-terminal kinases (JNKs) for treating cancer
#1441Generation of replication competent viruses for therapeutic use
#1442Combination gene delivery vehicles
#1443Antigenic peptides derived from telomerase
#1444Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma
#1445Biological glue based on thrombin-conjugated nanoparticles
#1446Method of converting the state of proteins
#1447Transglutaminase linkage of agents to tissue
#1448Method for treating inflammatory bowel disease
#1449Pi3k antagonists as radiosensitizers
#1450Methods and compositions for polypeptide engineering
#1451ActRII receptor polypeptides, methods and compositions
#1452Methods and compositions related to the modulation of intercellular junctions
#1453Treatment of HIV infection
#1454Inhibition of mitogen-activated protein kinases in cardiovascular disease
#1455Topical compositions comprising benfotiamine and pyridoxamine
#1456Methods and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras
#1457Adenoviral vectors having a protein IX deletion
#1458Pharmaceutical composition comprising a thymidine kinase polynucleotide
#1459Alpha 5 beta 1 and its ability to regulate the cell survival pathway
#1460Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect
#1461Adenoviral vectors having a protein IX deletion
#1462ALK7 and myostatin inhibitors and uses thereof
#1463Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
#1464Target cell-specific adenoviral vectors containing E3 and methods of use thereof
#1465Use of Yops as caspase inhibitor
#1466Tumor specific oligosaccharide epitopes and use thereof
#1467Methods and compositions for treating neuropathies
#1468Lung volume reduction using glue compositions
#1469Targeting damaged lung tissue
#1470Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer
#1471Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof
#1472Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
#1473Chimeric adenoviruses for use in cancer treatment
#1474Inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases
#1475Compositions and methods for treating disorders associated with abnormal phosphate metabolism
#1476Method for treating glaucoma
#1477Methods of enhancing stem cell engraftment
#1478Materials and methods for treating or preventing oxalate-related disease
#1479Peptide inhibitors of protein kinase C
#1480Cancer treatment by metabolic modulations
#1481Compositions and methods of use of targeting peptides for diagnosis and therapy
#1482Kinases involved in the regulation of energy homeostasis
#1483Methods of treating parkinson's disease using viral vectors
#1484Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease
#1485Method for inhibiting the formation of seromas using factor XIII
#1486Method for screening FGFR-4 agonists
#1487Breast cancer associated polypeptide
#1488Prevention and treatment of mycoplasma-associated diseases
#1489Methods and compositions for increasing CD4lymphocyte immune responsiveness
#1490Natural menaquinone 7 compositions
#1491Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases
#1492Remedy for ischemic heart failure
#1493Systemic delivery of serum stable plasmid lipid particles for cancer therapy
#1494Histone h3methyltransferase polypeptide
#1495Presbyopia treatment by lens alteration
#1496Presbyopia treatment by lens alteration
#1497Modified adenovirus containing a fiber replacement protein
#1498Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
#1499Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof
#1500Detection of sphingosine kinase activity and sphingosine kinase agonist or antagonist activity